BeiGene Stock (NASDAQ:BGNE), Quotes and News Summary

Q: What sector and industry does BeiGene (BGNE) operate in?

BeiGene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BeiGene Stock (NASDAQ: BGNE) stock price, news, charts, stock research, profile.

Open	$135.750
Close	$138.990
Volume / Avg.	203.615K / 249.137K
Day Range	134.680 - 142.220
52 Wk Range	126.968 - 266.665
Market Cap	$14.523B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	-
Days to Cover	10.28

Recent News

HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Lululemon Issues Weak Outlook, Joins Nike And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining by around 0.1% on Friday.

Avi Kapoor

FDA Approves BeiGene's First Drug Candidate Produced Through Its Immuno-Oncology Program For Esophageal Cancer

FDA approves BeiGene's Tevimbra for esophageal squamous cell carcinoma, offering hope for patients after prior chemotherapy. Tevimbra's efficacy was demonstrated in the RATIONALE 302 trial with significant survival benefit compared to chemotherapy. Coming to the U.S. in 2nd half of 2024.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Oct 23

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About BeiGene Ltd

Sector

Health Care

Industry

Biotechnology

BeiGene Ltd is a commercial-stage biotechnology company. It is engaged in the discovery and developm...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BeiGene (BGNE) stock?

You can purchase shares of BeiGene (NASDAQ: BGNE) through any online brokerage.

View our list of the best stock brokerages.

Who are BeiGene's (BGNE) competitors?

Other companies in BeiGene’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

What is the target price for BeiGene (BGNE) stock?

The latest price target for BeiGene (NASDAQ: BGNE) was reported by B of A Securities on Monday, April 8, 2024. The analyst firm set a price target for 164.30 expecting BGNE to rise to within 12 months (a possible 18.21% upside). 15 analyst firms have reported ratings in the last year.

Current Stock Price for BeiGene (BGNE)?

The stock price for BeiGene (NASDAQ: BGNE) is $138.99 last updated April 23, 2024 at 4:00 PM EDT.

Does BeiGene (BGNE) pay a dividend?

There are no upcoming dividends for BeiGene.

When is BeiGene (NASDAQ:BGNE) reporting earnings?

BeiGene’s Q1 earnings are confirmed for Monday, May 6, 2024.

Is BeiGene (BGNE) going to split?

There is no upcoming split for BeiGene.

What sector and industry does BeiGene (BGNE) operate in?

BeiGene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-